Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. The company offers OsteoSponge, a natural scaffold for cellular in-growth; OsteoSelect DBM Putty, which can be compressed into bony voids; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated and terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, an aseptically processed and viable bone allograft; and nanOss products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier. It also provides sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. In addition, the company offers cervical products comprising Spider cervical plating, Streamline OCT, and CervAlign systems; thoracolumbar products consisting of Axle-X interspinous fusion, Streamline MIS spinal fixation, Streamline TL spinal fixation, and HPS 2.0 hybrid performance systems; and Silex sacroiliac joint fusion systems. Further, it provides interbody products comprising Calix for cervical and thoracolumbar applications, Irix-C Cervical and Irix-A lumbar integrated dusion systems, and Fortilink implants; and interlaminar stabilization products, such as Coflex device for lumbar spinal stenosis; and CoFix implants for back and disc pain. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana.
The current price of XTNT is $0.56 USD — it has increased by +2.76% in the past 24 hours. Watch Xtant Medical stock price performance more closely on the chart.
What is Xtant Medical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Xtant Medical stocks are traded under the ticker XTNT.
Is Xtant Medical stock price growing?▼
XTNT stock has fallen by -0.91% compared to the previous week, the month change is a -2.16% fall, over the last year Xtant Medical has showed a +13.6% increase.
What is Xtant Medical market cap?▼
Today Xtant Medical has the market capitalization of 78.12M
When is the next Xtant Medical earnings date?▼
Xtant Medical is going to release the next earnings report on April 30, 2026.
What were Xtant Medical earnings last quarter?▼
XTNT earnings for the last quarter are 0.01 USD per share, whereas the estimation was -0.01 USD resulting in a +278.1% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Xtant Medical revenue for the last year?▼
Xtant Medical revenue for the last year amounts to 234.53M USD.
What is Xtant Medical net income for the last year?▼
XTNT net income for the last year is -32.9M USD.
How many employees does Xtant Medical have?▼
As of April 01, 2026, the company has 217 employees.
In which sector is Xtant Medical located?▼
Xtant Medical operates in the Health Care sector.
When did Xtant Medical complete a stock split?▼
The last stock split for Xtant Medical was on February 14, 2018 with a ratio of 1:12.